Reaction
Cryopyrin Associated Periodic Syndrome reporting signals
As of the last recalculation, Cryopyrin Associated Periodic Syndrome appears in 192 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 2,370.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canakinumab | 106 | 2,370.0 | 2,393.6 |
| Ciclesonide | 32 | 305.4 | 306.2 |
| Desoximetasone | 32 | 218.3 | 218.7 |
| Anakinra | 20 | 145.8 | 146.0 |
| Valacyclovir | 32 | 99.6 | 99.7 |
| Omalizumab | 39 | 62.0 | 62.0 |